NBF Hall of Fame

NBF introduced its Hall of Fame in 2007 recognizing a prestigious and select group of NBF grant recipients who leveraged their early-career grant funding into successful careers in transfusion medicine, cellular therapies, or patient blood management and who demonstrated exemplary leadership within the field.

This important recognition was reinstated annually in 2015 inducting one to three new members each year that meet the following criteria:

Eligibility Criteria

  • Must be an NBF Scholar: completed NBF funded research.
  • Must be a current AABB Individual Member.
  • Must have served on three or more AABB committees or workgroups. (AABB Board of Directors, NBF/NBFRET Board of Trustees and TRANSFUSION Editorial Board included.)
    • If an NBF Scholar who is an active AABB member has served on at least one AABB committee or workgroup, the individual, at the request of NBF staff, can be considered for Hall of Fame eligibility through their submission of a one-page justification addressing volunteer leadership service. Such service can be with other professional hematology or transfusion medicine-related organizations or within their own institution (e.g. directing a transfusion medicine fellowship program).
  • Demonstrates a successful career and exemplary leadership through commitment, forward thinking, and various contributions to the field.

2022 Members

Don L. Siegel, PhD, MDDon L. Siegel, PhD, MD

Professor of Pathology & Laboratory Medicine
Director, Division of Transfusion Medicine & Therapeutic Pathology
Director, Clinical Cell & Vaccine Production Facility
Director, Fellowship Program in Transfusion Medicine
Perelman School of Medicine
University of Pennsylvania

“NBF funding provided me with the support necessary to be “retooled” in state-of-the-art laboratory methods that had developed after my time in graduate school during my subsequent years of medical training. I was then positioned to address scientific problems known to exist at the start of my career -- but most importantly was prepared for what unexpectedly came along years later such as the opportunity to “hack” the immune system and create engineered T cells.”


2021 Members

Brian R. Curtis, PhD, D(ABMLI), MT(ASCP)SBBBrian R. Curtis, PhD, D(ABMLI), MT(ASCP)SBB

Senior Director Diagnostic Hematology
Director Platelet & Neutrophil Immunology Lab
Senior Investigator, Blood Research Institute
Versiti, Wisconsin

“NBF funding helped finance my early research studies that led to publications, name recognition in the field, and a cascade of career advancing opportunities.”


Cheryl Lobo, PhDCheryl Lobo, PhD

Head, Blood-Borne Parasites
Lindsley Kimball Research Institute
New York Blood Center

“Being recognized as an NBF awardee supported my laboratory both financially and professionally. Not only did the grant monies focus my work on parasite biology in a translational research direction but also allowed me to forge strong connections with a collaborative network of transfusion medicine researchers.”


2020 Members

Eldad A. Hod, MDEldad A. Hod, MD

Associate Professor
Department of Pathology and Cell Biology
Columbia University Medical Center and New York Presbyterian Hospital

“The NBF award was a critical source of funding at a critical time in my early investigative career. It allowed me to generate the data needed to jumpstart my extramurally-funded research program.”


Sean Stowell, MD, PhDSean Stowell, MD, PhD

Medical Director, Center for Apheresis, Brigham and Women's Hospital, Harvard Medical School
Associate Director, National Center for Functional Glycomics, Harvard Medical School

“The NBF grant was the first grant I had written or received. It came at a critical time in my career when I was determining whether it was tenable to choose a career as a physician-scientist in transfusion medicine and in so doing, had a significant impact on my career.”


2019 Members

Neil Blumberg, MDNeil Blumberg, MD

Professor of Pathology and Laboratory Medicine
Director, Blood Bank/Transfusion Medicine
University of Rochester Medical Center

“This NBF funding in 1989 was one of my first extramural grants. It provided validation of our work on transfusion immumomodulation and post-operative infections, which has been central to my career. These NBF studies provided data suggesting that avoiding allogeneic transfusions of red cells improved clinical outcomes.”


Brian Custer, PhD, MPHBrian Custer, PhD, MPH

Vice President, Research and Scientific Programs
Director, Epidemiology and Health Policy Science
Vitalant Research Institute
Adjunct Professor, Laboratory Medicine
University of California San Francisco

“The NBF funding literally launched my extramurally funded research career, showing me I could successfully obtain grant funding.”


Beth H. Shaz, MDBeth H. Shaz, MD

Deputy Director, Marcus Center for Cellular Cures
Professor of Pathology
Duke University

AABB Past President

“Receiving NBF funding was a critical step in my academic career. Through the process I learned how to write a grant, how to successfully and systematically perform studies and publish their results, and about blood donation. I am thankful for the funding support.”


2018 Members

Jeffrey L. Carson, MDJeffrey L. Carson, MD

Provost, Rutgers Biomedical Health Science, New Brunswick
Distinguished Professor of Medicine,
Richard C. Reynolds, M.D., Chair, General Internal Medicine,
Rutgers Robert Wood Johnson Medical School

“NBF funding was one of the first national competitive peer reviewed research grants that I was awarded and it contributed significantly to establishing me as an independent investigator in transfusion medicine.”


Stella T. Chou, MDStella T. Chou, MD

Chief, Division of Transfusion Medicine
The Children's Hospital of Philadelphia
Associate Professor, Pediatrics
Perelman School of Medicine at the University of Pennsylvania

“I feel tremendous gratitude for the NBF grant which provided critical support during my early career in transfusion medicine which was essential for establishing my research laboratory and translational program to improve transfusion therapy for patients with sickle cell disease.”


Diane Krause, MD, PhDDiane Krause, MD, PhD

Anthony N. Brady Professor, Departments of Laboratory Medicine, Cell Biology and Pathology
Associate Director
Yale Stem Cell Center
Medical Director
Clinical Cell Processing Laboratory
Yale University School of Medicine

“The research award that I received from the National Blood Foundation (NBF) was very important to me and came at a critical time early in my career. The ability to receive funding and the amount of money received were both key in my now having uninterrupted NIH funding and multiple exciting discoveries on the transcriptional regulation of early hematopoiesis.”


2017 Members

Jose Cancelas, MD, PhDJose Cancelas, MD, PhD

Professor & Director/Chairman
Hoxworth Blood Center
Leader, Stem Cell Group and Translational Core Laboratories
Director, Translational Core Laboratories
Cincinnati Children's Hospital Medical Center
University of Cincinnati College of Medicine

“The National Blood Foundation was a crucial step in my career since it provided me with the first source of extramural funding to support my research project in 2005. As a result, I was able to generate data that cemented the fundamentals of my research endeavors.”

Laura Cooling, MD, MSLaura Cooling, MD, MS

Professor, Department of Pathology
University of Michigan
Associate Medical Director of Transfusion Medicine
Medical Director for the Cellular Therapy and Immunohematology Reference Laboratories

“The NBF was an important step in my early career as a young faculty member transitioning into academic medicine. It provided a foundation for subsequent clinical and translation studies during my career in the areas of immunohematology and bone marrow transplantation support.”

James D. Gorham, MD, PhDJames D. Gorham, MD, PhD

Medical Director, Transfusion Medicine Services
Chief, Division of Laboratory Medicine, and Professor, Department of Pathology
University of Virginia

“NBF was the very first grant for my nascent research lab as an independent Principal Investigator and was instrumental in launching our early research efforts focusing on cytokines in transfusion biology, tolerance, and autoimmunity. The NBF holds a special place in my heart.”

2016 Members

Jeanne E. Hendrickson, MDJeanne E. Hendrickson, MD

Professor of Laboratory Medicine and Pediatrics
Medical Director of the Apheresis Service
Associate Medical Director of the Transfusion Medicine Service
Yale University

“Early career funding by the National Blood Foundation was instrumental in allowing Dr. Hendrickson the time and resources to develop her red blood alloimmunization research ideas. The NBF grant that Dr. Hendrickson was awarded also provided her with confidence that her research ideas were worthy of exploration.”

Steven L. Spitalnik, MDSteven L. Spitalnik, MD

Executive Vice-Chair of Laboratory Medicine and Professor
Department of Pathology & Cell Biology
Columbia University

“I received an NBF grant soon after arriving at Columbia University. I had decided to take the risky step of radically changing my research focus to use mouse models to study poorly understood issues in transfusion medicine, such as the mechanisms underlying hemolytic transfusion reactions. This funding was critically important in allowing us to change our focus and succeed in a new area.”

Karina Yazdanbakhsh, PhDKarina Yazdanbakhsh, PhD

Executive Director of Research
Lindsley F. Kimball Research Institute (LFKRI)
New York Blood Center

“The NBF grant support allowed me to pursue a new exciting research direction in transfusion medicine and to secure my first R01 and American Heart Association grants. I am forever grateful to the NBF for providing me with the crucial support to jumpstart my career in transfusion medicine.”

2015 Members

Larry J. Dumont, MBA, PhDLarry J. Dumont, MBA, PhD

Vice President, Research and Scientific Programs
Director and Senior Investigator
Vitalant Research Institute
Denver, Colorado

The NBF funding was central to completion of my PhD, and has been a key in transitioning to an academic focus that provides a strong bridge between product development, academic research, education and delivery of clinical care. This has strengthened my contributions to the safe and efficacious care of patients.”

Jill R. Storry, PhDJill R. Storry, PhD

Associate Professor
Division Hematology & Transfusion Medicine
Department of Laboratory Medicine
Lund University

Technical Director
Clinical Immunology and Transfusion Medicine
Office of Medical Services

My NBF grant permitted me to establish myself in a new country and gave stability to my post-doctoral employment. Those early results led to further funding from other local sources, and to the discovery of a novel erythrocyte protein. NBF grants are an enormously important source of research funding in Transfusion Medicine and Cellular Therapy.”

James C. Zimring, MD, PhDJames C. Zimring, MD, PhD

Professor, Pathology
University of Virginia

My NBF award came at a crucial time, early in my career, when it was unclear in what direction my lab would develop. The support was indispensable in allowing me to develop a mature research program, focused on transfusion biology, which has been the basis of my research career.”

2007 Inaugural Members

James P. AuBuchon, MD, FCAP, FRCP(Edin)James P. AuBuchon, MD, FCAP, FRCP(Edin)

Happily retired, sailing the seven seas…
Former President and Chief Executive Officer
Bloodworks Northwest
AABB Past President

The support I received from NBF was critical in allowing me to start my career in radiolabeling and component improvement.

Michael P. Busch, MD, PhDMichael P. Busch, MD, PhD

Vitalant Research Institute
Senior Vice President
Professor of Laboratory Medicine

Although an investigator on grants prior to my NBF-grant in 1992, this was my first PI-status grant. The NBF grant led to a publication in Blood and development of the Viral Activation in Transfusion Study. Over the subsequent decades I have led dozens of similar studies with BSRI as the Central Laboratory.

Sunny Dzik, MDSunny Dzik, MD

Blood Transfusion Service
Massachusetts General Hospital

Participation in the NBF-- as an applicant, an awardee, a reviewer of grant applications, and as a financial contributor—has built strong and positive relationships during my career in academic Transfusion Medicine. I look at recent and current NBF awardees and I am extremely proud of their scientific achievements and their investigative enthusiasm. NBF is one of the best parts of our Profession. Congratulations and many thanks to those who make the NBF stronger each year.

Christopher D. Hillyer, MDChristopher D. Hillyer, MD

President and CEO
New York Blood Center

Professor, Department of Medicine
Weill Cornell Medical College
New York, New York

AABB Past President

The value of the NBF grant to me was substantial. It was seed funding at a point in my career when I would not have been able to get major, investigator initiated grants. It was peer reviewed at a very good and high level, allowing me to learn the process. These set the stage for me to get R01 and even P01- level funding. Through the NBF grant process, I was also able to meet other investigators and network in a way that supported my career development.

Paul D. Mintz, MDPaul D. Mintz, MD

Senior Vice President and Chief Medical Officer
Verax Biomedical Inc.

AABB Past President

The National Blood Foundation Grant I received played a key role in the transfusion medicine research program at the University of Virginia and in my career development. This award allowed us to study the relationship of platelet morphology to platelet recovery and survival and to learn the techniques required to radiolabel platelets and to perform these studies. We subsequently applied this knowledge to other research.”

Joann Moulds, PhD, MT (ASCP)SBBJoann Moulds, PhD, MT (ASCP)SBB

Retired and enjoying a budding career as a sommelier…
Formerly Scientific Director, Immunohematology Center
Grifols Diagnostic Solutions Inc.

My NBF grant allowed me to obtain the experience with molecular techniques as applied to blood groups that I needed to become a leader in the field of molecular immunohematology and become an advocate for the use of blood group genotyping in patient care.”

Sandra J. Nance, MS, MASCP, MT (ASCP) SBBSandra J. Nance, MS, MASCP, MT (ASCP) SBB

Former Senior Director,
National Laboratories for American Red Cross and American Rare Donor Program
Past Editor-In-Chief,
Immunohematology Journal of Blood Group Serology and Molecular Genetics
Former Adjunct Assistant Professor,
Division of Transfusion Medicine and Therapeutic Pathology
University of Pennsylvania

“AABB’s National Blood Foundation grant was the first grant I applied for and received which led to a subsequent publication reporting use of the Monocyte Monolayer Assay. These early research years as a PI on the AABB NBF Grant were formative and laid the foundation for my continuing research, presentations, publications, and review roles. It reinforced the importance of learning and teaching others. The NBF grant, becoming an NBF Scholar and inaugural inductee to the NBF Hall of Fame is a continuing source of pride along with having the MMA be used to predict transfused RBC survival of incompatible red blood cells over 35 years later.”

Marion Elizabeth Reid, FIMBS, PhD, DSc(Hon.)Marion Elizabeth Reid, FIMBS, PhD, DSc(Hon.)

Former Director of Immunohematology and Head Immunochemistry
New York Blood Center

The NBF is a very valuable stepping-stone for researchers. It follows the NIH format and gave me experience in grant writing.”


John D. Roback, MD, PhDJohn D. Roback, MD, PhD

Emory University School of Medicine

Although I received an NBF grant in 1998, when NIH funding was relatively abundant, the NBF award was absolutely critical for jump-starting my transfusion medicine research career and laying the groundwork for my later investigations. In today’s more challenging NIH funding climate, NBF awards are more important than ever for developing the next generation of transfusion medicine investigators.”

Christopher C. Silliman, MD, PhDChristopher C. Silliman, MD, PhD

Professor of Pediatrics and Surgery
School of Medicine
University of Colorado Denver

Senior Independent Investigator
Research Department
Bonfils Blood Center

The NBF was the first organization to take my data seriously and gave me working capital when no one else would. This has led to consistent extramural funding and a rewarding clinical and research career. I will be forever indebted.”

Edward Snyder, MD, FACPEdward Snyder, MD, FACP

Professor Laboratory Medicine and Pathology
Yale Medical School
Chair, Yale COI Committee
Vice-Chair, DSMB, Yale Cancer Center
Attending, Blood Bank YNHH
Director, Blood Bank Bridgeport Hospital
Co-Director Tissue Programs -Yale-New Haven & Bridgeport
Yale-New Haven Hospital

AABB Past President

The NBF provided me with funding to start my research in the field of blood filtration. That seed grant grew into a major research effort that afforded me the opportunity to publish papers, participate in local and national research symposia and be recognized as a useful committee member and advisor to National Organizations and Federal Agencies. That small grant of $5,200 paid large dividends and formed the foundation of my career in Transfusion Medicine.”

Connie M. Westhoff, SBB, PhDConnie M. Westhoff, SBB, PhD

Executive Scientific Director of Immunohematology and Genomics
New York Blood Center

The NBF grant brought my research career back to my first love – the field of transfusion medicine -- and the chance to contribute to improve transfusion therapy through genomics.”